The U.S. company is seeking to annul a decision by the European Commission to review its $8 billion acquisition of another U.S. business.
April 30, 2021 at 05:46 AM
1 minute read
Reporter
U.S. biotech firm Illumina has enlisted Slaughter and May and Covington & Burling in a legal action against the European Commission over its probe into the group’s $8 billion acquisition of fellow U.S. cancer screening business, GRAIL.
Illumina, which specialises in genetic sequencing, filed an action with the General Court of the European Union in Brussels on Thursday seeking to annul the Commission’s review, according to a statement by the San Diego-based company.
Presented by BigVoodoo
Celebrate outstanding achievement in law firms, chambers, in-house legal departments and alternative business structures.
The African Legal Awards recognise exceptional achievement within Africa s legal community during a period of rapid change.
Law firms & in-house legal departments with a presence in the middle east celebrate outstanding achievement within the profession.
A large and well-established Tampa company is seeking a contracts administrator to support the company's in-house attorney and manage a wide...
We are seeking an attorney to join our commercial finance practice in either our Stamford, Hartford or New Haven offices. Candidates should ...
We are seeking an attorney to join our corporate and transactional practice. Candidates should have a minimum of 8 years of general corporat...
MELICK & PORTER, LLP PROMOTES CONNECTICUT PARTNERS HOLLY ROGERS, STEVEN BANKS, and ALEXANDER AHRENS
